Activin, a member of the transforming growth factor-b superfamily, affords neuroprotection in acute brain injury, but its physiological functions in normal adult brain are largely unknown. Using transgenic (tg) mice expressing a dominant-negative activin receptor mutant under the control of the CaMKIIa promoter in forebrain neurons, we identified activin as a key regulator of c-aminobutyric acid (GABA)ergic synapses and anxiety-like behavior. In the open field, wildtype (wt) and tg mice did not differ in spontaneous locomotion and exploration behavior. However, tg mice visited inner fields significantly more often than wt mice. In the light-dark exploration test, tg mice made more exits, spent significantly more time on a well-lit elevated bar and went farther away from the dark box as compared to wt mice. In addition, the anxiolytic effect of diazepam was abrogated in tg mice. Thus the disruption of activin receptor signaling produced a low-anxiety phenotype that failed to respond to benzodiazepines. In whole-cell recordings from hippocampal pyramidal cells, enhanced spontaneous GABA release, increased GABA tonus, reduced benzodiazepine sensitivity and augmented GABA B receptor function emerged as likely substrates of the low-anxiety phenotype. These data provide strong evidence that activin influences pre-and postsynaptic components of GABAergic synapses in a highly synergistic fashion. Given the crucial role of GABAergic neurotransmission in emotional states, anxiety and depression, dysfunctions of activin receptor signaling could be involved in affective disorders: and drugs affecting this pathway might show promise for psychopharmacological treatment.
Introduction
Activins belong to the transforming growth factor-b (TGFb) superfamily and are now recognized as multifunctional regulatory proteins. In addition to their roles in development and hormonal regulation, recent studies revealed important new functions of activins in tissue repair, fibrosis and inflammatory disease in various organs, including the brain. 1 The predominant activin variants are homo-or heterodimers consisting of bA and/or bB subunits (activin A: bAbA; activin B: bBbB and activin AB: bAbB). Activins mediate their biological effects through heteromeric receptor complexes, consisting of type I and type II transmembrane serine/threonine kinase receptors. Upon ligand binding, one of the activin type II receptors (ActRII or ActRIIB) dimerizes with a type I receptor (ActRIA, ActRIB or activin receptorlike kinase 7), resulting in phosphorylation of the type I receptor by the type II receptor. 2, 3 Although we and others have firmly established a neuroprotective role of activin in acute brain injury, [4] [5] [6] it remained unclear whether activin also influences the operation of neuronal circuits under physiological conditions. To explore the functions of activin in normal adult brain, we recently generated transgenic (tg) mice expressing a dominant-negative mutant of activin receptor IB (dnActRIB) under the control of the CaMKIIa promoter. 7 The CaMKIIa promoter was chosen, because it drives expression of a transgene specifically in forebrain neurons, especially the hippocampus, and because it becomes active at a relatively late stage of development, typically the first to second postnatal week, as demonstrated in various tg mouse lines using this promoter. [8] [9] [10] The expression of the transgene in forebrain neurons and the efficient inhibition of activin-receptor signaling by the transgene product were verified in vivo using two independent tg mouse lines with different integration sites of the transgene. 7 These mice were macroscopically indistinguishable from their wild-type (wt) littermates. In hippocampal slices of dnActRIB mice, we found that the NMDA component of glutamatergic neurotransmission was decreased and, as a consequence, synaptic plasticity was impaired, causing a significant reduction in long-term potentiation (LTP) at the Schaffer-CA1 synapse. 7 These data were the first to demonstrate that endogenously produced activin is capable of modulating the performance of the major excitatory synapse in the brain. Here, we extended our study to the role of activin at the g-aminobutyric acid (GABA)ergic synapse. GABA is the major inhibitory transmitter in the brain and has been implicated in a broad spectrum of physiological functions and disease states, including anxiety and depression. [11] [12] [13] We report the novel and unexpected finding that the loss of activin signaling in forebrain neurons readjusts essential features of GABAergic neurotransmission in a behaviorally relevant fashion.
Materials and methods

Animals
The tg mice express dnActRIB with a C-terminal c-Myc epitope under the control of the CaMKIIa promoter and regulatory elements as previously described. 7 The founder mice were created by microinjection of fertilized oocytes from B6D2F2 Â C57BL/6 mice. Tg mice were backcrossed into the C57BL/6 strain for 6-10 generations before used for the experiments described in this study. Experiments were performed with mice from two different lines (line 1, L1 and line 3, L3), which displayed the highest level of overexpression of the transgene compared to the endogenous gene and which revealed the same phenotype in previous experiments. 7 Only hemizygous tg mice and their wt littermates were used for experiments. The mice were housed and fed according to federal guidelines. Animal experiments and procedures for slice preparation were carried out according to the guidelines and with the approval of the local authorities.
Behavioral testing
Male and female mice aged 2.5-5 months were housed in groups of 3-5 in cages of 37 Â 21 cm. They had access to food and water ad libitum and were maintained on a 12 h light-dark cycle. All behavioral tests were performed in the light phase of the cycle. Diazepam was dissolved in 10% ethanol (EtOH), 40% propylene glycol and 50% water to a concentration of 10 mg ml À1 and then diluted in 0.9% saline to a concentration of 0.1 mg ml
À1
. 30 min before testing, 0.5 mg diazepam per kg body weight or vehicle was injected intraperitoneally. For sedation, the animals received an isoflurane inhalation anesthesia (2% isoflurane) for 1 min prior to the injection from which they recovered within a few minutes. Locomotor activity and emotionality were analyzed using an open-field activity assay. Each mouse was naive to the test apparatus. The test arena was constructed of a plastic plate (65 Â 65 cm) and was divided into 25 squares by lines drawn on the floor of the plate. It was surrounded by a 5 cm high plastic wall. The 16 squares bounded to the walls of the test arena were referred to as outer squares and the remaining ones as inner squares. Once per day, on 4 consecutive days, the animals were placed onto a corner square of the arena, facing the corner and allowed to freely explore the open field for 5 min per trial. During these periods, the numbers of entered outer and inner squares were counted. An entry into a square was defined as having the two forelimbs in the square at one time. After each trial the plate was cleaned with 70% EtOH. The light-dark exploration test was derived from similar tasks to test the conflict of the mice between the tendency to explore a novel environment vs the aversive properties of a brightly lit open field. 14, 15 The apparatus consisted of a white, wooden bar (75 cm length, 10.5 cm width) placed 50 cm above the ground. On one end of the bar a dark plastic box with 9 cm side length and a 4 cm wide opening on the side facing the bar was placed. The uncovered part of the bar was illuminated by a headlight. The test started by placing the animals into the box. Then they were allowed to freely stay in the box or to exit it in order to discover the open part of the bar for 5 min. After each trial the bar and the box were cleaned with 70% EtOH. The performance was quantified by counting the number of exits out of the box and the time the mice stayed on the open part. An exit was defined as the whole body of the animal, except the tail, being outside of the box. In addition, we counted the number of mice entering the outer segment of the bar in each group.
Data were stored on digital videotapes. Tracking the open-field behavior of the animals was performed offline with a custom-written LabView-based software. Experimenters were blind regarding the genotype of the animals. Since none of the electrophysiological recordings showed any difference between the two lines of tg mice, we decided to pool the behavioral data from lines 1 and 3 tg mice.
Electrophysiology
Using standard procedures, transverse hippocampal slices (350 mm thick) were prepared from the brain of adult mice (2-6 months old), which were deeply anesthetized with halothane prior to decapitation. After dissection, slices were incubated in modified artificial cerebrospinal fluid (ACSF), in which MgCl 2 was elevated to 3.0 mM and CaCl 2 was reduced to 1.0 mM, initially in warmed (35 1C) ACSF for 20 min and then maintained at room temperature in the same solution. Normal ACSF contained (mM): NaCl, 125; KCl, 3; CaCl 2 , 2; MgCl 2 , 2; NaH 2 PO 4 , 1.25; NaHCO 3 , 25; D-glucose, 10 (pH 7.4). In the storage and recording chamber, slices were kept submerged in ACSF, which was constantly gassed with 95% O 2 -5% CO 2 . For electrophysiological measurements, individual slices were transferred to the recording chamber that was mounted on the stage of an upright microscope (Zeiss Axioskop). ACSF was constantly exchanged by means of a gravity-driven superfusion system during experiments (flow rate 2-3 ml min À1 ). All measurements were performed at room temperature. Dodt infrared gradient contrast in conjunction with a contrast-enhanced CCD camera (Hamamatsu Photonics, Herrsching, Germany) served to identify pyramidal cells in the hippocampal CA1 region. Whole-cell currents were filtered at 2 kHz and sampled at 10 kHz using an Axopatch 200 amplifier in conjunction with a Digidata 1200 interface and pClamp 9 software (all from Molecular Devices, Sunnyvale, CA, USA). Patch pipettes were filled with (mM): CsCl 130; MgCl 2 , 3; ethylene glycol tetraacetic acid (EGTA), 5; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5; Na 2 -ATP, 2; Na-GTP, 0.3 and QX-314, 5 (pH 7.25-7.30). For recordings of baclofen-induced currents, K-gluconate (130 mM) was substituted for CsCl, and QX-314 was omitted in the pipette solution. The electrode resistance ranged from 2.5 to 5 MO when filled with internal solution. Series resistance in whole-cell configuration was about 10-25 MO, which was compensated by 60-80%. Currents were recorded at À70 mV, after correcting for liquid junction potentials.
Constant current pulses (pulse width 0.1 ms) of 60-300 mA were delivered at 0.05 Hz through a concentric bipolar electrode located in stratum radiatum to evoke synaptic responses in CA1 pyramidal cells. GABA A receptor-mediated inhibitory postsynaptic currents (IPSCs) were pharmacologically isolated by perfusing slices with the ionotropic glutamate receptor antagonist, kynurenic acid (2 mM). Local puff application of exogenous GABA was achieved by pressure ejection using pipettes fabricated from sharp electrodes. The puffer pipette was placed adjacent to the cell, and was filled with 50-300 mM GABA dissolved in modified ACSF in which bicarbonate was replaced with HEPES/Na-HEPES (25 mM) to avoid pH changes in the pipette solution. Brief (6-10 ms) pressure pulses (0.5-2 psi) were delivered at 0.1 Hz to evoke GABA A receptor-mediated currents in the presence of tetrodotoxin (TTX) and antagonists for GABA B receptors (GABA B Rs) and glutamate receptors. Unless otherwise stated, all drugs were added to the bathing medium at known concentrations. CGP 55845 and diazepam were prepared as 10 mM stock solution in 100% dimethyl sulfoxide. CGP 55845, GABA, QX-314, (S)-SNAP 5114 and TTX were purchased from Tocris (Cologne, Germany). Recombinant activin A and follistatin (FS-288) were obtained from R&D Systems (Minneapolis, MN, USA). All other drugs came from Sigma (Deisenhofen, Germany).
Data analysis was performed off-line with Clampfit 9 (Molecular Devices). Peak amplitude, 10-90% rise time and area above the curve of GABA A response were measured for evoked IPSCs. An automated fitting routine was used to fit evoked responses to mono-and bi-exponential decay equations. In some cases, stratum radiatum stimulus-induced IPSCs were fitted adequately by monoexponential decay. Spontaneous events were analyzed using an automated event detection algorithm with an amplitude threshold set as 4 * s noise . Analysis was confined to GABA A, fast IPSCs, which were identified based on rise times of < 2 ms. 16 Peak amplitude and interevent intervals were measured for each IPSC. To characterize the decay kinetics of fast IPSCs, a subset of events was selected for exponential curve fitting. Events were selected only if no other event occurred within 100 ms of the peak. The decay of averaged currents was fitted with single or the sum of two exponential functions using the Levenberg-Marquardt nonlinear least-squares algorithm. Typically, spontaneous events were described best by two exponential components. The weighted decay time constant (T W ) was calculated as
, where T 1 and T 2 are the time constants of the first and the second exponential functions, respectively, and A 1 and A 2 are the current amplitudes measured at time, t, equal to T 1 and T 2 , respectively. 16 
Statistical analysis
Data are expressed as mean ± s.e.m. Statistical comparisons of the electrophysiological data were performed using one-way analysis of variance test or Student's t-test. Kolmogorov-Smirnov test was used for comparing cumulative probabilities. The behavioral data were statistically analyzed using the distribution-free Mann-Whitney U-test. P-values < 0.05 were considered significant, P-values < 0.01 were considered highly significant.
Results
dnActRIB mice display a low-anxiety phenotype and respond poorly to diazepam
The open field is a widely used conflict paradigm, in which the innate drive to explore a novel environment is opposed by the tendency to stay in protective areas, namely the outer fields flanked by walls. Thus mice avoid the unsafe and aversive appearance of the inner fields and spend typically much more time in the outer than in the inner fields. Surprisingly, dnActRIB mice strongly deviated from this behavioral pattern in that they crossed significantly more frequently the inner fields of the arena, as compared to wt mice (Figures 1a and d ; wt mice n = 10, tg mice n = 12). This did not result from a difference in spontaneous locomotion or exploratory behavior, since neither the total number of all entered fields (Figure 1b ) nor the number of entered outer fields ( Figure 1c ) varied significantly between the groups. Since the numbers of entered inner and outer fields have to sum up, it might seem contradictory that the mice were only different with respect to inner, but not to outer or total fields. This apparent discrepancy can be resolved by taking into account that the number of entered inner fields was about one order of magnitude smaller than that of entered outer fields. Thus the difference between wt and tg mice that is significant at the level of inner fields becomes diluted at the level of outer (and total) fields. It is worth noting that dnActRIB mice displayed the reduced anxiety-like behavior throughout the 4-day testing period, during which the overall exploratory drive markedly declined as the test arena became increasingly familiar (Figures 1b-d ). This suggests that the low-anxiety phenotype of the dnActRIB mice is a constant behavioral trait rather than being appreciably modulated by experience and adaptation.
The light-dark exploration test (Figure 2a ) represents another well-established behavioral avoidance paradigm in which the curiosity of the mice gets in conflict with the potential threat emanating from the elevated and illuminated bar. Compared to wt mice (n = 10), tg mice (n = 12) left the box significantly more often and spent more time on the bar within the 5 min test period (Figures 2b and c) . Furthermore, the percentage of mice daring to explore the outer segment of the elevated bar was much higher in the tg than in the control group (Figure 2d ). We next examined the behavioral response of wt and tg mice to an anxiolytic dose of the benzodiazepine, diazepam (0.5 mg per kg i.p.), which acts on GABA A receptors (diazepam: wt n = 7, tg n = 8; vehicle: wt n = 5, tg n = 5). At this concentration, the drug did not induce sedation, as indicated by its lacking effect on locomotor activity. The overall distance covered by wt (9050 ± 1095 pixels) and tg mice (11 082 ± 880 pixels) while exploring the bar was not significantly different after diazepam injection. Consistent with its wellestablished anxiolytic action, diazepam treatment of wt mice produced a pronounced increase in the number of exits (Figure 2b ), in the exploratory time spent on the bar (Figure 2c) , and in the visits of the outer segment (Figure 2d ). In contrast to wt animals, diazepam treatment of dnActRIB mice failed to produce a significant increase in the number of exits (Figure 2b ) or in the time spent outside the box (Figure 2c ), nor did diazepam alter the percentage of tg animals visiting the outer segment ( Figure 2d ). The apparently lacking anxiolytic action of diazepam in tg mice might be explained in two ways, which do not have to be mutually exclusive: First, in tg mice, GABAergic synapses in neuronal circuits controlling anxiety-related behavior are less sensitive to diazepam as compared to wt mice. Second, the anxiolytic Activin, GABA and anxiety F Zheng et al action of diazepam is, in principle, preserved in tg mice, but their behavioral response displays saturation. Wt and tg mice started from different anxiety levels, but attained very similar levels with diazepam, possibly reflecting the ceiling for anxiolytic effects in this paradigm. To resolve this issue and unravel the mechanisms underlying the low-anxiety phenotype of dnActRIB mice, we explored the role of activin at GABAergic synapses by electrophysiological means.
Tonic GABAergic inhibition is enhanced in hippocampal slices from dnActRIB mice It is widely accepted that the activation of GABA A Rs can exert two temporally and functionally distinct effects on neuronal excitability commonly referred to as phasic and tonic inhibition. 17, 18 The phasic component results from the brief pulse of action potential-dependent or -independent GABA release and is mediated by synaptic GABA A Rs. In contrast, tonic inhibition is caused by low ambient GABA levels acting predominantly on extrasynaptic GA-BA A Rs. Since the anxiolytic effects of EtOH and neurosteroids have been attributed to a selective enhancement of tonic GABA inhibition, [19] [20] [21] we wondered whether an endogenous increase in the tonic component might possibly account for the lowanxiety phenotype of dnActRIB mice. To address this issue, we performed whole-cell recordings from adult CA1 pyramidal cells in slices from wt and tg mice. Since we used a high Cl À pipette solution, both phasic and tonic GABA A R-mediated currents were recorded as inward currents at a holding potential (V h ) of À70 mV. Tonic GABA inhibition was determined as the steady-state inward current that was sensitive to the GABA A R antagonist bicuculline (50 mM). Consistent with previous reports, 22, 23 we observed only a small tonic GABA current in CA1 pyramidal cells from wt mice (11.3 ± 1.1 pA, n = 10). In striking contrast, CA1 pyramidal cells from two independent lines of dnActRIB mice (L1 and L3), 7 displayed significantly stronger tonic GABA inhibition (L1 25.5±3.3 pA, n = 6, P = 0.006; L3 27.4±2.3 pA, n = 5, P = 0.001; Figures 3a and b; left columns). To demonstrate that the effect of the transgene on GABAergic neurotransmission can be mimicked in adult wt hippocampus by acutely blocking the action of activin, we pre-incubated wt slices for 5 ± 1 h with the soluble activin-binding protein follistatin (FS-288, 0.2 mg ml À1 ), which inhibits the effects of activin. 6 Consistent with the effect of the dominant-negative activin receptor, our data indicate that even shortterm neutralization of endogenous activin is capable of producing a significant increase in the GABA tonus of mature wt pyramidal cells (Figure 3b ; blue column in left histogram, n = 5).
Reduced GABA uptake would offer a possible explanation for the enhanced GABA tonus in dnActRIB hippocampi. GAT1 is the main GABA transporter in the hippocampus and is predominantly, but not exclusively expressed in neurons. 23 In addition to rapidly clearing released GABA from the synaptic cleft, GAT1 plays also an essential role in the extent of tonic inhibition in the CA1 region, since it removes diffusely distributed GABA with high efficacy from the extracellular space. 24 In fact, blockade of GAT1
with NO-711 (5 mM) in the presence of GABA B R antagonist CGP 55845 (1 mM) raised the tonic current of wt pyramidal cells into the range typically observed in cells from dnActRIB hippocampi (25.7 ± 6.9 pA, n = 7, P = 0.03). By contrast, NO-711 produced no further increase in tonic inhibition in dnActRIB hippocampi (L1 n = 5; L3 n = 6; Figure 3b , middle columns). This could be possibly interpreted as a sign of impaired GAT1 function in dnActRIB hippocampi. We therefore decided to challenge GAT1 and evoked IPSCs in CA1 pyramidal cells by electrical stimulation in stratum radiatum, where GAT1 expression is particularly prominent. 25 We then determined the properties of IPSCs in control and dnActRIB hippocampi in the absence and presence of Activin, GABA and anxietyNO-711. When compared at half-maximal amplitudes (WT 2.26 ± 0.09 nA, n = 21; L1 2.30 ± 0.08 nA, n = 26; L3 2.30 ± 0.06 nA, n = 27), the kinetics of evoked IPSCs in wt and dnActRIB hippocampi were indistinguishable, which would be inconsistent with an appreciable deficit in GAT1 function (rise time: wt 3.7±0.4 ms, L1 3.8±0.3 ms, L3 3.6±0.3 ms; decay time constant: wt 83.8±5.5 ms, L1 82.8±4.8 ms, L3 83.5 ± 5.2 ms). Furthermore, in the presence of CGP 55845, NO-711 (5 mM) produced virtually identical effects on evoked IPSCs in wt and tg CA1 pyramidal cells (Figures 3c and e) . In addition to slowing the decay of IPSCs, NO-711 reduced the amplitudes of IPSCs in both preparations in a virtually identical fashion. Previous work has shown that the reduction of IPSC amplitude by NO-711 results from an increased GABA level in the synaptic cleft, which in turn promotes slow desensitization of synaptic GABA A Rs. 26 Since the effects of NO-711 on IPSC kinetics and amplitude were all present in dnActRIB hippocampi, GAT1 function should not be compromised. We then used (S)-SNAP 5114 to suppress GAT2 and GAT3, which are primarily, but not exclusively, expressed in glial cells. 27 (S)-SNAP 5114 (10 mM) did not affect the kinetics of evoked IPSCs (Figures 3d and e) , but produced a comparable reduction of IPSC amplitudes in wt (78±6% of control, n = 6) and tg CA1 pyramidal cells (81±7% of control, n = 9), suggesting that GAT2/GAT3 are also intact in dnActRIB hippocampi.
We next employed TTX (1 mM) to suppress spontaneous spiking activity. Although TTX did not affect tonic inhibition in wt hippocampi (n = 5), it completely abrogated the enhanced tonus in hippocampi from both tg mouse lines (L1 n = 4; L3 n = 6) so that the amplitude of the remaining tonic GABA current in the dnActRIB hippocampi was indistinguishable from that of wt hippocampi (Figure 3b, right columns) . This strongly implicated enhanced GABA release in the pronounced tonic GABA inhibition of dnActRIB hippocampi.
Frequency of spontaneous and miniature IPSCs is enhanced in dnActRIB hippocampus
To elaborate on this hypothesis, we recorded spontaneous IPSCs (spIPSCs) in CA1 pyramidal cells of WT, L1 and L3 hippocampi. In neurons from both tg mouse lines, the frequency of spIPSCs was significantly higher than in wt neurons (Figure 4b ). The mean decay time constant of spIPSCs did not differ between dnActRIB and wt hippocampi (WT 17.8 ± 0.6 ms, n = 47; L1 17.3 ± 0.6 ms, n = 50, P = 0.25; L3 16.4±0.6 ms, n = 37, P = 0.11) and the mean amplitude of spIPSCs was smaller in dnActRIB 49 Hz, n = 24, P = 0.011) were significantly enhanced in tg cells. Insets depict cumulative probability histograms of interevent intervals of spIPSCs and mIPSCs. (c) Amplitudes of spIPSCs (WT 53.6 ± 3.6 pA, n = 47, L1 44.6 ± 1.5 pA, n = 50, P = 0.020; L3 44.0 ± 2.1 pA, n = 37, P = 0.042), but not of mIPSCs (WT 39.7 ± 2.4 pA n = 23; L1 40.3±2.8 pA, n = 14, L3 41.6±2.7 pA, n = 24, P > 0.05) were larger in wt than in tg neurons. Insets depict cumulative amplitude distribution in wt and tg neurons. *P < 0.05.
Activin, GABA and anxiety F Zheng et al hippocampi (Figure 4c ). We next examined the characteristics of miniature IPSCs (mIPSCs) in wt and dnActRIB hippocampi, using TTX (1 mM) to suppress action potential-dependent GABA release ( Figure 4a ). As for the spIPSCs, the frequency of mIPSCs was significantly higher in CA1 pyramidal cells from dnActRIB hippocampi than from wt hippocampi (Figure 4b ), whereas the mean decay time constants showed no difference (WT 17.2 ± 0.9 ms; L1 16.1 ± 1.3 ms, L3 15.9 ± 1.1 ms, P > 0.05). However, unlike our findings from spIPSCs, the mean amplitude of mIPSCs was virtually identical in all three groups (Figure 4c ). This suggests that the apparently smaller mean amplitude of spIPSCs in dnActRIB hippocampi might be secondary to the higher frequency of spIPSCs, as the probability of synchronized release events producing large-amplitude spIPSCs might have declined as their overall frequency increased.
Recombinant activin restores normal GABA tonus in dnActRIB hippocampus
We next tested if the phenotype can be rescued by addition of exogenous activin. For this purpose, dnActRIB hippocampi were treated for 5 ± 1 h with recombinant activin A (22 ng ml
À1
). Figure 5a shows a typical sequence of spIPSCs from a pyramidal neuron of line 1 (L1) hippocampus without activin treatment (left trace) and from a pyramidal cell of L1 hippocampus with preceding activin treatment (right trace). The effects of activin treatment (n = 7) on the frequency and amplitude of spIPSCs (spIPSCs), and on the resulting bicuculline-sensitive GABA tonus are summarized in Figures 5b and c, respectively. For comparison, the average values from wt cells are included as black columns in each histogram. The data clearly show that exogenous activin fully restores the normal level of tonic inhibition in dnActRIB hippocampus (Figure 5c ). This result demonstrates that the level of activin is rate limiting under our experimental conditions, indicating that endogenous activin is trapped by the large number of additional activin binding sites provided by the dominant-negative receptors.
We also examined the effect of exogenous activin on wt hippocampi. In contrast to its pronounced action in dnActRIB hippocampus, exogenous activin (22 ng ml À1 for 5 ± 1 h) had no effect on the frequency and amplitude of spIPSCs and on GABA tonus in wt CA1 pyramidal cells (Figures 5b and c) . This strongly suggests that in adult wt hippocampus activin receptors should be tonically activated by endogenous activin in a saturating (or near-saturating) fashion.
Diazepam response is attenuated in dnActRIB hippocampus
A salient feature in the behavioral testing of dnActRIB mice was the apparently lacking effect of diazepam on anxiety-related behavior. To elucidate the cellular basis of this phenomenon, we examined the modulation of evoked IPSCs by diazepam (3.5 mM) in CA1 pyramidal cells of normal and dnActRIB hippocampi using about 40% of the maximum IPSC amplitude. Preceding experiments had shown that the inputoutput relationship of IPSCs and the efficacy of the GABA A R agonist, muscimol, were not altered in dnActRIB hippocampi (Supplementary Figure 1) . Application of diazepam increased the amplitude and slowed the decay of IPSCs in CA1 pyramidal cells of wt mice (n = 9; Figure 6a) . In striking contrast, diazepam completely failed to enhance the amplitude of IPSCs in both lines of tg mice (L1 n = 9; L3 n = 10; Figure 6a ). As a remaining effect, however, the drug was still capable of prolonging IPSCs as indicated by its effect on decay time constant (Figure 6a) . To demonstrate the postsynaptic nature of the reduced response to diazepam in dnActRIB hippocampi, we delivered brief GABA pulses (50-300 mM) into the vicinity of the cell under study. Postsynaptic effects of GABA were isolated by perfusion with TTX and antagonists for glutamate and GABA B Rs (see Materials and methods). Intensity and duration of GABA puffs were set to mimic the amplitude and kinetics of evoked IPSCs. Again, diazepam (3.5 mM) failed to augment the amplitude of current responses to GABA puffs in hippocampi from tg mice (n = 5), but reliably did so in wt hippocampi (n = 5; Figure 6b ). Similar to its effect on the kinetics of IPSCs in dnActRIB hippocampi, diazepam retained part of its modulatory action in that it slowed the decay of GABA-evoked waveforms. In view of the postsynaptic nature of the altered diazepam response in dnActRIB hippocampus, we considered the possibility that the relative expression of benzodiazepine-sensitive a-subunits (a1, 2, 3, 5) might be reduced in favor of benzodiazepine-insensitive a-subunits (a4, 6). When using furosemide, which is a selective blocker of the latter, 28 we observed a significantly stronger suppression of IPSCs in neurons from tg than from wt mice (Figure 6c ). Since a6-containing GABA A Rs are not expressed in hippocampus 29 and are much more sensitive to furosemide than a4GABA A Rs (IC 50 6 vs 162 mM), 28 the effect of 0.6 mM furosemide in dnActRIB hippocampi can be best explained by assuming a more pronounced contribution of a4GABA A Rs to the IPSC. In addition to potentiating IPSCs, diazepam has been reported to augment the small tonic GABA current in CA1 pyramidal cells. 30 However, in contrast to its differential modulation of phasic inhibition, the diazepam-induced increase in holding current was not significantly different between CA1 pyramidal cells from wt hippocampi (11.1 ± 1.5 pA, n = 16) and dnActRIB hippocampi (10.3 ± 2.4 pA, n = 15, P = 0.76).
Pre-and postsynaptic effects of GABA B Rs are augmented in dnActRIB hippocampus We next investigated whether the disruption of activin signaling also bears significance on electrophysiological processes controlled by GABA B Rs. Presynaptic GABA B Rs serve as autoreceptors or (at non-GABAergic synapses) as heteroceptors inhibiting transmitter release, whereas postsynaptic GABA B Rs activate a G-protein-coupled inwardly rectifying K þ (GIRK) conductance. 31 In the first set of experiments, we examined paired pulse depression of two IPSCs evoked 200 ms apart. In wt pyramidal cells, the amplitude of the second IPSC was reduced to 64 ± 3% of that of the first IPSC (n = 17). By contrast, paired-pulse depression amounted to only 74±2% (n = 41, P = 0.003) of the first IPSC in dnActRIB hippocampi. In wt neurons, paired-pulse inhibition was independent of the activation of GABA B autoreceptors, since the GABA B R antagonist, CGP 55845 (2 mM), failed to alter the IPSC ratio (relative reduction of second IPSC 64±4%, n = 10). In neurons from tg mice, however, CGP 55845 further reduced pairedpulse inhibition (81 ± 2%, n = 22, P = 0.022), indicating an involvement of presynaptic GABA B Rs. The differential role of GABA B autoreceptors in wt and dnActRIB hippocampi became even more evident when we examined the increasing depression of IPSCs during a train of stimuli delivered in the y-frequency range (Figures 7a and b) . Although frequency depression was not appreciably influenced by CGP55845 (1-2 mM) in wt neurons (n = 10), it was strikingly attenuated in pyramidal cells from tg mice (L1 n = 11, L3 n = 11, Figures 7a and b) . It is worth noting that GABA B autoreceptors have also a role in regulating GABA release in normal hippocampus, but only at distal dendritic synapses that produce much slower IPSCs and require stimulation in stratum lacunosum-moleculare. 32 As the regular mechanism of frequency-dependent depression of (fast) IPSCs is largely lost in dnActRIB hippocampi, this deficit seems to be compensated for by the recruitment of the GABA B R-dependent feedback loop that is normally only operative at the remote, slow inhibitory synapses.
We next measured GIRK current responses to increasing concentrations of the GABA B R agonist baclofen (0.01-10 mM). As expected, GIRK currents reversed polarity very close to the calculated K þ equilibrium potential (E K À95 mV) under our recording conditions (Figure 7c ). Because we used physiological external K þ , the I-V relationship of the GIRK current did not display considerable inward rectification in the hyperpolarizing direction. Consistent with previous publications, 33 baclofen activated the GIRK current in wt pyramidal cells with a half maximal effective concentration in the low micromolar range (Figure 7d) . In marked contrast, baclofen was significantly more effective in inducing GIRK current responses in pyramidal cells from tg mice, as indicated by the leftward shift of the dose-response curve and the increase in maximum GIRK current (Figure 7d ).
Discussion
We report here the novel and unexpected finding that the targeted disruption of activin signaling in mature hippocampus affects several essential features of GABA A R-and GABA B R-mediated neurotransmission in a behaviorally relevant fashion (Figure 8) . In dnActRIB hippocampi, spontaneous GABA release was enhanced as indicated by the higher frequency of spIPSCs and mIPSCs compared to wt hippocampi. Furthermore, paired-pulse inhibition of IPSCs was significantly reduced, underscoring the notion of altered release properties in tg hippocampi. At the postsynaptic side, enhanced tonic inhibition and reduced diazepam sensitivity emerged as distinctive features of GABA A R-dependent neurotransmission in dnActRIB hippocampi (Figure 8 ). In the absence of an apparent deficit in GABA uptake, the higher frequency of spontaneous, action potential-dependent vesicular GABA release most likely accounts for the stronger tonic inhibition in tg CA1 pyramidal cells, consistent with its TTX sensitivity. In strong support of this notion, Glykys and Mody 34 showed that the vesicular GABA release responsible for phasic inhibition is indeed the main source of the ambient GABAmediating tonic inhibition in mouse hippocampus. 34 The presynaptic nature of enhanced GABA tonus in tg hippocampus was a surprising finding, given that the expression of dnActRIB was driven by the Activin, GABA and anxiety F Zheng et al CaMKIIa promoter, which is active in pyramidal cells, but not in interneurons. 35 Previous studies using this promoter found indeed no evidence for the expression of their respective transgenes in hippocampal interneurons. 9, 10 Assuming that this also holds for dnActRIB, how could a transgene that is only expressed in pyramidal cells, affect GABA release from interneurons? A possible explanation is that the large number of additional activin binding sites generated from the transgene product in pyramidal cells trap activin molecules, thereby making them unavailable for activin receptors on interneurons. In view of the low level of activin in normal adult hippocampus 36 and the high diffusibility of activin, 37 this additional effect of the dominant-negative receptor approach might become relevant in our preparation. Alternatively, activin might act on pyramidal cells to control the expression and/or release of factors that modulate the activity of interneurons in a paracrine fashion. This issue was resolved when we pre-incubated hippocampal slices from tg mice in recombinant activin. The rationale for this experiment was that, if endogenously produced activin is indeed captured by dominant-negative activin receptors on pyramidal cells, exogenous application should supply sufficient activin to restore normal GABA tonus. In contrast, pre-incubation in activin should have no effect, if the change in presynaptic properties resulted from a retrograde messenger that is released from pyramidal cells. The experiment clearly showed that exogenous activin fully restored the normal level of tonic inhibition in tg hippocampus. Therefore, it seems likely that the dominantnegative activin receptors on pyramidal neurons largely remove endogenously produced activin from the extracellular space, thereby preventing its binding to interneurons. The overshooting responses in spIPSC frequency and amplitude to acute exogenous activin in dnActRIB hippocampi lend further support to this notion, since the shortage of activin should have enhanced the sensitivity of interneurons to this factor. Together with the action of exogenous follistatin in adult wt hippocampus (Figure 3b ), the effect of exogenous activin in adult dnActRIB hippocampi has a second important corollary. Because exogenous activin acts so quick in dnActRIB hippocampi, restoring the normal level of tonic inhibition within few hours, the enhanced GABA tonus is highly unlikely to represent the sequelae of disrupted activin signaling during development.
A minor contribution to the enhanced GABA tonus might also come from the presumed redistribution of GABA A R subunits in favor of furosemide-sensitive a4GABA A Rs. Recent evidence from CA1 pyramidal cells suggests indeed that, besides a5GABA A Rs, 30, 38 a4GABA A Rs (combined with d-subunit) participate in tonic inhibition. 22 Since a4GABA A Rs are benzodiazepine-insensitive, their apparent upregulation in tg CA1 pyramidal cells (at the expense of benzodiazepine-sensitive GABA A Rs) could be in part responsible for the reduced diazepam sensitivity in tg CA1 pyramidal cells. In addition, the loss of activin signaling might possibly affect the phosphorylation status of GABA A Rs, thereby influencing their allosteric modulation by benzodiazepines. 39, 40 Interestingly, mice heterozygous for the GABA A -receptor g2 subunit display an almost inverse phenotype to that of dnActRIB mice, so that in g2 þ /À mice, enhanced behavioral inhibition toward natural aversive stimuli is associated with heightened diazepam responsiveness. 41 However, immunohistochemistry (Supplementary Figure 2 ) did not provide evidence for an altered expression pattern of the g2 subunit in hippocampi from dnActRIB mice. 42 The same was true for the d-subunit, 42 which targets GABA A receptors to extrasynaptic sites, where they produce a tonic inhibitory current (Supplementary Figure 2) . Finally, immunohistochemistry did not reveal any gross abnormalities in the expression pattern of GABA A R a1-5 subunits 42 and the GABA B R2 subunit (Supplementary Figure 2) . 43 Thus the deviations of GABAergic neurotransmission at the postsynaptic side are likely to result from more subtle changes in dnActRIB hippocampi that escape immunohistochemical detection, such as changes in the ratio of functional receptors at cell surface vs internalized receptors, differences in subunit assembly, or altered receptor phosphorylation.
Consistent with data from GAT1 knockout hippocampi, the enhanced level of ambient GABA did not produce a tonic activation of GIRK channels through GABA B Rs. 23 However, the higher efficacy of the GABA B R agonist baclofen to activate GIRK current in tg neurons, as compared to wt neurons, clearly demonstrated that the GABA B R-dependent pathway is another postsynaptic target of activin. By downregulating GABA B R-activated GIRK currents, activin signaling would be expected to raise the excitability of CA1 pyramidal cells, enhance their firing probability and, by decreasing the shunting inhibition of incoming excitatory input, modify information processing and gain control. [44] [45] [46] In addition to its role in anxiety-like behavior, tonic GABAergic inhibition in the hippocampus might also influence cognitive functions. In fact, mutant mice lacking the a5 subunit of the GABA A receptor, which is important for tonic inhibition (see above), showed enhanced learning and memory. 47 The idea that activin, by reducing GABA tonus, would also improve cognitive performance is particularly intriguing in light of our previous study on the role of activin in excitatory neurotransmission. There, we reported that activin augments NMDA receptor currents and promotes hippocampal LTP. 7 It appears therefore conceivable that activin regulates GABA A and NMDA receptor function in a delicately balanced fashion that bears significance on learning and memory, but this interesting hypothesis remains to be tested in future behavioral studies.
How can we relate the abnormal features of GABAergic neurotransmission in the hippocampus to the behaviorally disinhibited, low-anxiety phenotype of dnActRIB mice? Presumably overshadowed by its essential and intensely studied function in spatial learning and memory, the hippocampus has long been known to play a prominent role in certain forms of emotional processing, with special emphasis on anxiety-related behavior. 48 The hippocampus is thought to control behavioral inhibition under conditions of conflict, when, for example, a novel, but potentially threatening object or environment raises a conflict between approach and avoidance. Consequently, lesions of the hippocampus produced anxiolytic effects in ethologically based tests similar to the ones employed in our study. 49 Furthermore, a recent study reported that brain-derived neurotrophic factor levels in hippocampus, but not in amygdala, were positively correlated to the expression of unconditioned anxiety observed in the elevated plus maze test. 50 Thus the behavioral phenotype of dnActRIB mice might well arise from cellular and synaptic alterations in the hippocampal network. Low EtOH and neurosteroids are thought to reduce anxiety by augmenting tonic GABA inhibition (see above). By analogy, it seems therefore reasonable to assume that the enhanced GABA tonus is, at least in part, responsible for the low-anxiety phenotype of dnActRIB mice. Particularly astounding was the close parallel between the abrogated anxiolytic effect of diazepam in tg mice and the diminished potentiation of IPSCs in their hippocampi, which strongly suggests a causal relationship.
In view of its dense interconnectivity with the hippocampus, one might wonder whether the amygdala should not play a significant role in the lowanxiety phenotype of our tg mice. However, the following reasons argue against the notion that the altered behavior is predominantly attributable to amygdala dysfunction. While the promoter of our transgene is also active in amygdala, 51 in situ hybridization studies revealed a much weaker signal of the transgene in this region as compared to hippocampus (data not shown). Since pronounced overexpression of the transgene-derived truncated receptor compared to the endogenous receptor is required to obtain a dominant-negative effect, activin signaling should not be significantly disrupted in the amygdala. Furthermore, despite an appreciable overlap in emotional processing, hippocampus and amygdala are thought to play quite distinguishable roles in anxiety and fear-related behavior. Most importantly in the context of our study, the amygdala, unlike the hippocampus, does not appear to be essential for the normal performance in ethologically based tests of anxiety, such as the conflict paradigms employed in our study. 48 In view of the pronounced effects of activin signaling on GABA B Rs, an obvious question is whether they also play a role in anxiety. Recent knockout and pharmacological studies lend indeed increasing support to the notion that GABA B Rs are involved in anxiety-related behaviors. 52 For example, both GABA B(1) R-and GABA B(2) R-deficient mice display higher levels of anxiety than their wt counterparts in several ethological tests including the lightdark box. 53, 54 Furthermore, the novel positive GA-BA B R modulator, GS39783, proved to be anxiolytic in, among others, the light-dark box and the elevated plus maze. 55 Our findings agree nicely with these studies, given that the enhanced GABA B R responsiveness of dnActRIB mice was associated with decreased anxiety in the open-field and the lightdark exploration test. Thus it is well conceivable that activin influences anxiety-related behavior also through the modulation of GABA B R-dependent pathways.
Given the extensive clinical co-morbidity of anxiety and depression, it came as a surprise that GABA B Rs appear to play opposite roles in anxiety and depression. In fact, the same GABA B(1) R-and GABA B(2) Rdeficient mice that show increased anxiety exhibit less depressant-like behavior in the forced swimming test, a widely used animal model of depression that is sensitive to antidepressant treatment, but not to anxiolytic drugs. 53, 54 In a remarkable coincidence, the same, apparently counterintuitive effects on anxiety and depression seem to hold for activin. Although we report here that genetic disruption of activin signaling decreased anxiety-related behavior, a recent study showed that hippocampal infusion of activin exerted antidepressant-like activity in the forced swimming test. 56 Although caution is warranted when inferring abnormal emotional processing from altered behavior in animal tasks, it is tempting to speculate that, by tuning GABAergic neurotransmission, activin is essential to provide the optimal balance between anxiety and depression. In this scenario, activin signaling would adjust the level of anxiety to avert the daredevil behavior of dnActRIB mice, while, at the same time, preventing the behavioral immobility associated with depression. With its presumed pivotal role in the regulation of normal emotional behavior, activin may emerge as one of the proposed 'endogenous homeostatic agents' 40 that modulate the global operation of neuronal circuits through a multitude of highly coordinated actions at the cellular and synaptic level. Our study also strongly suggests that preclinical and clinical studies exploring alterations in activin signaling should offer new insights into mood disorders and reveal novel targets in psychopharmacology.
